SGS

This technical bulletin discusses major regulatory updates, introduced by the FDA and EMA, regarding nitrosamines and SGS proposed risk assessment method for compliance.

This whitepaper will look at how integrating the SEC-MALS method at an earlier stage in the development process will accelerate speed-to-clinic without compromising patient safety.

This case study will examine the subject of single-use plastics used in biopharmaceutical manufacturing and extractables & leachables from the perspective of the contract research organization.